Status:
COMPLETED
Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Mersin University
Conditions:
Idiopathic Pulmonary Fibrosis (IPF)
Sarcopenia
Eligibility:
All Genders
18+ years
Brief Summary
Sarcopenia negatively affects the prognosis of chronic diseases. However, the importance of sarcopenia in patients with idiopathic pulmonary fibrosis (IPF) has been less emphasized. The aim of the stu...
Detailed Description
The study was designed as a cross-sectional study.
Eligibility Criteria
Inclusion
- Being over 18 years of age
- Signing the informed consent form
- Having a diagnosis of IPF for at least one month
Exclusion
- Pregnancy
- History of cancer within the last 5 years
- History of lung surgery
- History of neuromuscular disease
- Active pulmonary tuberculosis
- Active respiratory tract infection
- Inability to perform pulmonary function tests
- Presence of a pacemaker
- History of systemic steroid use within the past 3 months
- Inability to use a hand dynamometer
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07178197
Start Date
December 1 2022
End Date
December 31 2023
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mersin University Faculty of Medicine
Mersin, Mersin, Turkey (Türkiye)